The future of cfDNA in cancer care looks promising, with ongoing research focused on improving detection technologies, validating clinical applications, and integrating cfDNA analysis into routine clinical practice. Advances in liquid biopsy and bioinformatics are expected to enhance the accuracy and utility of cfDNA in cancer management, making it an indispensable tool for personalized oncology.
